ABT vs STUB · P/E 25, rev $44.33B vs rev $1.75B
Abbott Laboratories (ABT) versus StubHub Holdings, Inc. (STUB) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
StubHub Holdings, Inc. (STUB) is a internet content & information company listed on NYSE.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported STUB revenue for 2025-12-31 was $1.75B. Net income was -$1.91B. Revenue was down 1.4% from 2024-12-31 to 2025-12-31. STUB currently screens at market cap $4.33B.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. STUB currently screens at market cap $4.33B.
Not investment advice. Open the ABT and STUB stock pages for the full models.
Not investment advice.